Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

Citius Pharmaceuticals to be Added to Russell 2000® Index

PR Newswire June 7, 2021

ImpediMed Announces Next Generation of SOZO® Digital Health Platform Software

PR Newswire June 7, 2021

Synaptogenix Announces Approval for Nasdaq Stock Market Listing

PR Newswire June 7, 2021

Relmada Therapeutics Announces Participation in Goldman Sachs 42nd Annual Global Healthcare Conference

PR Newswire June 7, 2021

Zimmer Biomet Announces New Appointments to Executive Leadership Team

PR Newswire June 7, 2021

Innovative Analytical Software for Enhanced Data Acquisition and Analysis

PR Newswire June 7, 2021

Thermo Fisher Scientific Collaborates with the University of Sheffield to Advance Oligonucleotide Characterization and Analytical Workflows

PR Newswire June 7, 2021

Incisive Genetics Announces The Appointment Of Dr. Kevin Chow As President

PR Newswire June 7, 2021

Lipocine to Present at the Lytham Partners Summer 2021 Investor Conference

PR Newswire June 7, 2021

Kintara Therapeutics Set to Join Russell Microcap® Index

PR Newswire June 7, 2021

Moderna and Medison Pharma partner to commercialize Moderna's COVID-19 vaccine across Central Eastern Europe and Israel

Canada NewsWire June 7, 2021

Ginkgo Bioworks Announces R&D Collaboration with Sumitomo Chemical to Develop More Sustainable Bio-Based Chemicals for Multiple Industries

PR Newswire June 7, 2021

Autobahn Labs Incubator Announces Partnership With Cold Spring Harbor Laboratory To Advance Novel Science To The Clinic

PR Newswire June 7, 2021

RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study

PR Newswire June 7, 2021

United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia

PR Newswire June 7, 2021

Article on CD40 agonistic antibodies published in Expert Opinion on Biological Therapy

PR Newswire June 7, 2021

OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO Annual Meeting

PR Newswire June 6, 2021

Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication

PR Newswire June 6, 2021

Innovent and HUTCHMED Release Phase 1b preliminary Results of TYVYT (Sintilimab Injection) plus Fruquintinib as a Third Line Treatment for Advanced Colorectal Cancer at ASCO Annual Meeting 2021

PR Newswire June 6, 2021

Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries

PR Newswire June 6, 2021